Population Pharmacokinetics of Polymyxin B in Acutely Ill Adult Patients
Sign Up to like & getrecommendations! Published in 2018 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.01475-17
Abstract: ABSTRACT Polymyxin B (PB) has reemerged as a common treatment against multidrug-resistant Gram-negative pathogens. However, nephrotoxicity remains a significant dose-limiting side effect, and contemporary pharmacokinetic (PK) data are limited. This study sought to evaluate PB… read more here.
Keywords: acutely ill; polymyxin acutely; population pharmacokinetics; pharmacokinetics polymyxin ... See more keywords